Stock Region Watchlist
4 Stocks Making Moves This Monday.
4 Stocks Making Moves This Monday
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Hey there,
Welcome to your Monday market rundown. Before we dive in, a quick reminder: This newsletter is for informational and entertainment purposes only. I'm not a financial advisor, and this isn't financial advice. Always do your own research before making any investment decisions.
Now, let's get to the good stuff. The market is kicking off the week with some serious shake-ups. Here’s what’s on my radar today, September 22, 2025.
1. Metsera ($MTSR): The Big Buyout
Wow. Just wow. Pfizer is making a massive play, snapping up Metsera in a deal worth up to $7.3 billion. If you've been following the obesity drug space, you know it's white-hot. We're talking a potential $150 billion market by the early 2030s, and this acquisition puts Pfizer right at the center of the action.
My Take: Honestly, this move is a no-brainer for Pfizer. They need to bolster their pipeline, and Metsera’s oral and injectable treatments are exactly the kind of innovation that gets Wall Street excited. Seeing the stock pop nearly 60% in premarket tells you everything you need to know about market sentiment. This wasn’t just a good move; it was a necessary one for Pfizer to stay competitive. The weight-loss drug race is the new space race, and Pfizer just launched a rocket.
2. Compass ($COMP): A Real Estate Behemoth is Born
In a move that’s sending ripples through the real estate world, Compass is merging with Anywhere Real Estate. This all-stock deal creates a combined company valued at a cool $10 billion. This isn't just two companies joining forces; it's a strategic play to create a dominant force in the industry.
My Take: The real estate market has been tough, and consolidation like this is often a sign of a shifting landscape. I’m intrigued. Merging could cut costs and expand their footprint significantly. It’s a bold move to try and own the market. For traders, keep an eye on some key levels. A break above $8.56 could signal some bullish momentum, while a dip below $8.00 might bring the bears out. This one will be interesting to watch unfold.
3. Kenvue ($KVUE): The Slow and Steady Winner
Remember when Johnson & Johnson spun off its consumer health division? Well, Kenvue is proving to be a solid, standalone player. With powerhouse brands like Tylenol, Listerine, and Band-Aid in its corner, the company is quietly carving out a strong position.
My Take: Let's be real, $KVUE isn't the kind of stock that's going to double overnight. It's the opposite of a meme stock. But in a volatile market, there’s something incredibly appealing about a company that sells products people buy no matter what the economy is doing. It's a defensive play with a reliable dividend. In my opinion, every portfolio needs a few boring, steady earners like this. It’s the kind of stock that helps you sleep at night.
4. Fox Corporation ($FOXA): Content is Still King
In the chaotic world of streaming wars, Fox is holding its ground by focusing on what it does best: live sports and news. While everyone else is chasing subscribers with expensive dramas, Fox is doubling down on can't-miss live events that keep advertisers happy.
My Take: I think Fox's strategy is smarter than it gets credit for. Live content is one of the few things that can still draw a massive, simultaneous audience. That’s gold for ad revenue. It gives them stability in a media landscape that feels like it’s changing by the second. For the short term, watch for a potential breakout above $63.80. On the flip side, a fall below $60.62 could indicate some weakness. It's a fascinating mix of old-media muscle and new-media savvy.
That's all for today! It looks like a busy week ahead. Keep your eyes on the charts and your strategies sharp.
Talk soon,
The Stock Region Team
Disclaimer: All content in this newsletter is for informational and educational purposes only and should not be construed as financial advice. The views and opinions expressed are our own. Investing in the stock market involves risk, including the potential loss of principal. Please consult with a licensed financial professional before making any investment decisions. We are not liable for any losses or damages arising from the use of this information.
You nailed it on Fox's live content stratgey - while everyone else is burning billions on scripted content that gets binged once, Fox's sports and news inventory is DVR-proof and commands premium CPMs. The $63.80 technical level is interesting timing too, given that NFL viewership has been tracking ahead of last year. One thing I'd add: their FanDuel optionality (18.6% stake) gives them a hedge that other traditional broadcasters don't have - gambling integration could unlock another revenue stream as sports betting penetration grows.